SNY - Weight Loss Drugs Like Wegovy Could Have Linked Anesthesia Complications European Medicines Agency To Investigate | Benzinga
The European Medicines Agency (EMA) is set to address concerns related to patients taking drugs such as Novo Nordisk A/S's (NYSE: NVO) Wegovy, Ozempic, and their counterparts potentially experiencing complications during anesthesia that could lead to pneumonia.
Earlier, the European Union and the U.K. initiated examining the safety data of Ozempic (semaglutide) and Saxenda (liraglutide), medications for Type 2 diabetes and weight loss, respectively, following reports of suicidal or ...